Analysis of the limitations of hepatitis B surface antigen expression in soybean cell suspension cultures
- PMID: 17534624
- DOI: 10.1007/s00299-007-0379-7
Analysis of the limitations of hepatitis B surface antigen expression in soybean cell suspension cultures
Abstract
Soybean cell suspension cultures were transformed using Agrobacterium tumefaciens harboring pHBS/pHER constructs to express hepatitis B surface antigen (HBsAg). The transformed colonies were selected and analyzed for the expression of HBsAg by PCR, reverse transcription (RT) PCR, Western blot and ELISA analysis. The maximum expression of 700 ng/g F.W. was noted in pHER transformed cells. The highest expressing colonies were used to initiate the cell suspension cultures and the expression of HBsAg was estimated periodically. The expression levels were reduced drastically in cell suspension cultures compared to the colonies maintained on semi-solid medium. Various parameters were studied to maximize the cell growth and to retain the expression levels. The supplementation of culture medium with a protease inhibitor, leupeptin hemisulfate could restore up to 50% of HBsAg expression in cell suspension cultures. This is the first report to investigate the possible cause and solution to the loss of recombinant protein expression levels in plant cell suspension cultures.
Similar articles
-
Expression of hepatitis B surface antigen in transgenic banana plants.Planta. 2005 Oct;222(3):484-93. doi: 10.1007/s00425-005-1556-y. Epub 2005 May 26. Planta. 2005. PMID: 15918027
-
Secretion of hepatitis B surface antigen in transformed tobacco cell suspension cultures.Biotechnol Lett. 2005 Jul;27(13):927-32. doi: 10.1007/s10529-005-7185-5. Biotechnol Lett. 2005. PMID: 16091888
-
Expression of hepatitis B surface antigen in tobacco cell suspension cultures.Protein Expr Purif. 2003 Nov;32(1):10-7. doi: 10.1016/j.pep.2003.07.004. Protein Expr Purif. 2003. PMID: 14680934
-
Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection.J Gastroenterol Hepatol. 2000 May;15(5):519-28. doi: 10.1046/j.1440-1746.2000.02187.x. J Gastroenterol Hepatol. 2000. PMID: 10847439 Review.
-
Soybean (Glycine max) transformation using immature cotyledon explants.Methods Mol Biol. 2006;343:397-405. doi: 10.1385/1-59745-130-4:397. Methods Mol Biol. 2006. PMID: 16988362 Review.
Cited by
-
Plant-made pharmaceuticals: exploring studies for the production of recombinant protein in plants and assessing challenges ahead.Plant Biotechnol Rep. 2023;17(1):53-65. doi: 10.1007/s11816-023-00821-0. Epub 2023 Feb 16. Plant Biotechnol Rep. 2023. PMID: 36820221 Free PMC article. Review.
-
The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.Int J Mol Sci. 2016 Oct 13;17(10):1715. doi: 10.3390/ijms17101715. Int J Mol Sci. 2016. PMID: 27754367 Free PMC article. Review.
-
The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects?Int J Mol Sci. 2013 Jan 21;14(1):1978-98. doi: 10.3390/ijms14011978. Int J Mol Sci. 2013. PMID: 23337199 Free PMC article. Review.
-
Plant-made vaccines against viral diseases in humans and farm animals.Front Plant Sci. 2023 Mar 28;14:1170815. doi: 10.3389/fpls.2023.1170815. eCollection 2023. Front Plant Sci. 2023. PMID: 37056490 Free PMC article. Review.
-
Preventing unintended proteolysis in plant protein biofactories.Plant Biotechnol J. 2008 Sep;6(7):633-48. doi: 10.1111/j.1467-7652.2008.00344.x. Epub 2008 Apr 28. Plant Biotechnol J. 2008. PMID: 18452504 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources